Providing hemostasis in anticoagulated blood by using zeolites

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 33/00 (2006.01) A61K 33/06 (2006.01) A61P 7/04 (2006.01)

Patent

CA 2684075

A method of clotting blood includes the step of administering a therapeutically effective amount of a composition comprising zeolite as the active ingredient to a wound from which the blood emanates. A method of arresting blood flowing from a wound includes the steps of providing a patient being inflicted with a bleeding wound and administering a therapeutically effective amount of a composition comprising zeolite as the active ingredient to the bleeding wound. A method of facilitating the formation of blood clots includes the step of contacting blood with a negatively charged surface wherein upon contacting the blood with the negatively charged surface a clotting mechanism is initiated. In any of the foregoing methods, the blood has a compromised ability to form clots. The blood may be from a person diagnosed with hemophilia or von Willebrand disease.

La présente invention concerne un procédé de coagulation sanguine incluant l'administration d'une quantité thérapeutiquement efficace d'une composition comprenant de la zéolite en tant qu'ingrédient actif, sur une blessure de laquelle s'écoule du sang. La présente invention concerne un procédé permettant d'arrêter l'écoulement sanguin provenant d'une blessure, ledit procédé incluant les étapes consistant à : choisir un patient souffrant d'une blessure en train de saigner, et administrer une quantité thérapeutiquement efficace d'une composition comprenant de la zéolite en tant qu'ingrédient actif sur ladite blessure en train de saigner. Un procédé favorisant la formation de caillots sanguins inclut la mise en contact du sang avec une surface chargée négativement, un mécanisme de coagulation étant initié lors de la mise en contact dudit sang avec la surface chargée négativement. Dans n'importe lequel des procédés précédents, la capacité du sang à former des caillots est compromise. Le sang peut provenir d'une personne diagnostiquée comme étant atteinte d'hémophilie ou de la maladie de Willebrand.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Providing hemostasis in anticoagulated blood by using zeolites does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Providing hemostasis in anticoagulated blood by using zeolites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Providing hemostasis in anticoagulated blood by using zeolites will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2009621

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.